NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 03:56PM ET
3.80
Dollar change
+0.12
Percentage change
3.26
%
Index- P/E- EPS (ttm)-5.40 Insider Own0.00% Shs Outstand1.74M Perf Week15.15%
Market Cap6.61M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-13.64%
Enterprise Value-2.28M PEG- EPS next Q- Inst Own4.84% Short Float- Perf Quarter-63.27%
Income-5.85M P/S330.50 EPS this Y- Inst Trans-1.30% Short Ratio0.95 Perf Half Y-84.63%
Sales0.02M P/B0.58 EPS next Y- ROA-70.50% Short Interest0.06M Perf YTD-86.19%
Book/sh6.54 P/C0.68 EPS next 5Y- ROE-81.24% 52W High53.10 -92.84% Perf Year-76.54%
Cash/sh5.57 P/FCF- EPS past 3/5Y16.39% - ROIC-49.87% 52W Low3.22 18.01% Perf 3Y-98.71%
Dividend Est.- EV/EBITDA- Sales past 3/5Y238.32% - Gross Margin-1573.17% Volatility7.45% 8.61% Perf 5Y-
Dividend TTM- EV/Sales-114.00 EPS Y/Y TTM78.04% Oper. Margin-29335.69% ATR (14)0.44 Perf 10Y-
Dividend Ex-Date- Quick Ratio19.49 Sales Y/Y TTM-39.68% Profit Margin-29418.82% RSI (14)40.74 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio19.49 EPS Q/Q83.64% SMA20-2.87% Beta2.91 Target Price60.00
Payout- Debt/Eq0.07 Sales Q/Q-94.10% SMA50-39.14% Rel Volume0.48 Prev Close3.68
Employees13 LT Debt/Eq0.03 EarningsFeb 26 SMA200-68.11% Avg Volume60.85K Price3.80
IPOJan 14, 2022 Option/ShortNo / Yes EPS/Sales Surpr.0.00% 0.00% Trades Volume29,275 Change3.26%
Jun-10-25 08:35AM
Jun-09-25 09:43AM
May-29-25 08:35AM
May-20-25 08:35AM
May-08-25 08:35AM
08:31AM Loading…
Mar-26-25 08:31AM
Feb-04-25 08:31AM
Dec-16-24 08:31AM
Nov-12-24 08:31AM
Oct-01-24 08:31AM
Sep-17-24 09:00AM
Aug-12-24 10:53PM
Jul-29-24 08:45AM
Jun-27-24 08:31AM
Jun-25-24 08:31AM
12:52PM Loading…
Jun-21-24 12:52PM
Jun-10-24 08:31AM
May-21-24 08:31AM
May-13-24 08:31AM
May-07-24 08:45AM
May-01-24 08:30AM
Apr-29-24 08:31AM
Apr-24-24 08:30AM
Apr-12-24 08:45AM
Apr-09-24 08:31AM
Apr-04-24 08:31AM
Mar-14-24 08:31AM
Mar-05-24 08:31AM
Feb-15-24 08:46AM
Feb-07-24 08:31AM
08:31AM Loading…
Feb-05-24 08:31AM
Jan-24-24 08:31AM
Jan-08-24 08:31AM
Jan-04-24 11:36AM
08:31AM
Jan-03-24 08:31AM
Jan-02-24 08:31AM
Dec-21-23 09:21AM
Dec-06-23 08:31AM
Dec-04-23 05:38PM
08:31AM
Nov-28-23 08:31AM
Nov-20-23 09:00AM
08:31AM
Nov-14-23 09:25AM
Nov-07-23 09:01AM
Oct-31-23 09:15AM
09:01AM
Oct-17-23 09:01AM
Oct-12-23 08:30AM
Sep-20-23 09:01AM
Sep-07-23 09:01AM
Sep-06-23 09:16AM
Sep-05-23 09:01AM
Aug-18-23 08:30AM
Aug-02-23 08:30AM
Jul-26-23 01:30PM
Jul-06-23 09:05AM
Jun-21-23 08:45AM
Jun-13-23 09:01AM
May-16-23 10:35AM
May-10-23 09:01AM
May-04-23 08:30AM
Apr-26-23 08:30AM
Apr-12-23 08:30AM
Apr-05-23 08:30AM
Apr-03-23 06:15AM
Mar-31-23 06:30AM
Mar-29-23 09:27AM
Mar-08-23 04:15PM
09:27AM
Mar-02-23 08:00AM
Feb-28-23 08:00AM
Feb-22-23 08:01AM
Jan-05-23 08:00AM
Jan-04-23 04:15PM
Dec-28-22 08:00AM
Nov-21-22 08:00AM
Nov-17-22 07:01AM
Nov-16-22 04:15PM
Nov-14-22 08:13AM
Nov-08-22 07:12AM
Oct-26-22 08:30AM
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Philibert RobertChief Medical OfficerSep 06 '24Buy0.2934,0759,7631,683,867Sep 10 05:22 PM
Dogan MeeshanthiniChief Technology OfficerSep 06 '24Buy0.2968,96520,000197,310Sep 09 11:08 AM
Dogan MeeshanthiniChief Executive OfficerSep 06 '24Buy0.2968,96520,0001,683,867Sep 09 11:01 AM